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Abstract 
Background: To determine frequency of 
thrombocytopenia in NICU and to find outcome of 
neonates receiving multiple platelet transfusion 
Methods: In this cross sectional study, neonates  
with thrombocytopenia ,  admitted to neonatal 
intensive care unit (NICU) were included. Two 
milliliter of blood was collected in EDTA bottle and 
kept on a roller mixer for mixing until a platelet 
count done by automated haematology analyzer. 
Stained film was examined under light microscope 
to rule out platelet clumps and to ensure that 
platelets had been spread evenly before actual count 
was done. At least two platelet readings were taken 
during admission. Platelets were transfused to 
neonates at platelet count less than 50,000. Any 
mortality in neonates receiving platelet transfusion 
was recorded during hospital stay.  
Results:The mean age of neonates was 2.92±2.20 
days, 63.2% were male and 36.8% were females. 
Thrombocytopenia was present in 41.4%, percentage 
of neonates. Platelet transfusions were administered 
to 12.7% and recorded mortality was 4.5%. 
Conclusion: Thrombocytopenia in neonates at 
NICU is higher while the outcome of neonates 
receiving platelet transfusion is appreciable. 
Key Word: Thrombocytopenia, NICU, Platelet 
transfusion 
 
Introduction 
 
Thrombocytopenia has been defined as a platelet 
count of less than 150 X 109/L. Almost 30% patients in 
the neonatal intensive care unit (NICU) can  develop 
thrombocytopenia at some period during their 
hospital admission. Platelet transfusions are 
commonly given to NICU patients, which may be 
unwarranted in some cases.1 Among term infants, only 
2% are thrombocytopenic at the time of birth. The 
occurrence of thrombocytopenia in neonates is quite 
variable and depends upon the population studied. 
Various conditions relating to mother or fetus are 
associated with thrombocytopenia like sepsis, birth 
asphyxia, low birth weight, prematurity, necrotizing 
colitis, exchange transfusion and some maternal 
conditions like hypertension, maternal idiopathic 
thrombocytopenic purpura . Sepsis is among the major 
causes of thrombocytopenia in neonatal age group  
and it rapidly aggravates within 24–48 hours after the 
start of infective process.2 There has been a strong 
association between low platelet count and clinically 
important bleeding and according to transfusion 
guidelines, platelet count thresholds are still 
universally used as transfusion triggers. Apart from 
platelet count, there are also some other important 
determining factors for the bleeding risk in neonates.3 
Thrombocytopenia is regarded as a significant 
independent risk factor for sepsis-related mortality in 
neonates falling in the very low-birth weight category.4 
Many studies have described no major difference 
between the incidence and development of 
thrombocytopenia by either gram positive or gram 
negative bacterial sepsis  but some studies have 
reported a higher rate of thrombocytopenia in 
neonates with gram negative sepsis. 5-9 
The frequency of severe thrombocytopenia in NICU is 
indirectly related to the birth weight and gestational 
age of the infant. Thrombocytopenia is a risk factor in 
cutaneous, pulmonary, gastrointestinal and CNS 
bleeding. Risk of thrombocytopenia in NICU is highest 
among preterm infants (baby born less than 36 weeks 
of gestation) and in low birth weight infants (having 
birth weight less than 2.5 kg) due to their restricted 
ability to compensate for the enhanced destruction of 
platelets.10 Newborns who suffer from acidosis or 
hypoxia due to birth trauma developed 
thrombocytopenia.11  
 
 Patients and Methods   
This was a cross sectional study, done in Pakistan 
Atomic Energy Commission (PAEC) General Hospital, 
Islamabad from January to  July 2015. Neonates of 
both gender admitted to NICU (neonatal intensive 
care unit) were included in study and neonates with 
congenital and chromosomal anomalies were excluded 
from study.  Two milliliter of blood was collected in 
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EDTA bottle and kept on a roller mixer for mixing 
until a platelet count done by automated haematology 
analyzer. As a quality control measure a thin smear of 
each sample was made and stained with field stain. 
Stained film was examined under light microscope to 
rule out platelet clumps and to ensure that platelets 
had been spread evenly before actual count was done. 
Samples which were free of platelet clumps were 
catered. Hence any error which may be due to falsely 
low platelet count was eliminated. At least two platelet 
readings were taken during admission. Sample 
collection was done under aseptic technique.  If 
platelet units were transfused to neonates, they were 
issued from blood bank of PAEC General Hospital 
with complete quality control of platelet unit. Platelets 
were transfused to neonates at platelet count of 50,000 
or below. Any mortality in neonates receiving platelet 
transfusion was recorded during hospital stay. 
Qualitative variables like gender, thrombocytopenia, 
platelet transfusion and mortality were calculated as 
frequencies and percentages. Effect modifiers like age, 
gender, birth weight and gestational age were 
controlled by stratification. Post-stratification chi-
square test was applied. P<0.05 was taken as level of 
significance. 
 
Results 
Majority of neonates (78.9%) were between 1-3 days of 
life. (Table 1).Eighty four ( 63.2%) were males while 
36.8% (n=49) were females. Seventeen (12.8%) 
neonates  had platelet count of less than 50X109/L 
(Table 2).Majority  of neonates (79.7%) had  birth 
weight between  3-4 kgs. Frequency of 
thrombocytopenia in NICU was 41.4%(Table 3). 
Majority (75.18%) had  no bleeding manifestations  
(Table 4).The neonates who received platelet 
transfusion were 12.7% (n=17)(Table 5). Mortality was 
4.5% (Table 6). 
 
Table 1:Age distribution of neonates(n=133) 
Age(days) Number Percentage 
1-3 105 78.9 
>3 28 21.1 
Mean±SD 2.92±2.20 
Table  2:Frequency and percentage 
 of platelet count 
Platelet count (X109/L) Number Percentage 
 <50 17 12.8% 
50-149 38 28.5% 
150-250 30 22.5% 
250-500 48 36.0% 
 
Table 3: Frequency and percentage of 
thrombocytopenia 
Thrombocytopenia Number Percentage 
Yes 55 41.4 
No 78 58.6 
Table 4: Bleeding manifestations-Frequency 
Bleeding 
manifestations 
Number Percentage 
Yes 33 24.82 
No 100 75.18 
Table 5: Frequency and percentage of neonates 
receiving platelet transfusion 
Transfusion     Number   Percentage 
No 116 87.3 
Yes 17 12.7 
Table 6: Outcome  and mortality 
Mortality Number Percentage 
Yes 6 4.5 
No 127 98.5 
 
Discussion 
Thrombocytopenia, defined as a platelet count of 
fewer than 150×109/l, is a common abnormal 
hematological finding in neonatal period. 
Approximately 30% of patients admitted in NICU 
develop a low platelet count at certain stage during 
their hospital stay. Platelet transfusions are commonly 
given to NICU patients, but may not be necessary in 
each and every case. 12 Improvements in transfusion 
guidelines are required for defining the safe lower 
limit for platelet transfusion in both sick and stable 
neonates. In addition, there is a necessity for setting up 
effective platelet transfusion practices for sick 
neonates, and improving the therapy for conditions 
aggravating thrombocytopenia. It remains unclear 
whether platelet transfusions are beneficial in the 
majority of infants with no or minor bleeding 
symptoms. Bleeding manifestations in our study were 
related to skin in most of cases. Some showed 
gastrointestinal bleeding.In a study of 3652 neonates, 5 
percent developed severe thrombocytopenia  ( platelet 
count less than 60,000 x 109/L) with 34, 39, and 28 
percent of infants having platelet count nadirs of <20, 
20 - 39 and >40 x 109/L, respectively.13-15 
There are conflicting reports regarding the connection 
between thrombocytopenia and intraventricular 
haemorrhage (IVH). Although no association was 
found by some researchers like Lupton et al, [16] Beiner 
et al  in their study , they  had noted a strong 
relationship between neonatal thrombocytopenia and 
IVH mainly between grades 3 and 4.16,17 In our study, 
the incidence of IVH in severely thrombocytopenic 
infants was not increased.  
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Majority of the neonates with a low platelet count have 
a moderate degree of thrombocytopenia which 
resolves when the underlying cause is appropriately 
managed. We recorded 12.78% of the cases who 
received transfusion, which is lower than in a study 
which revealed about 25% received one or more 
transfusion.18In a current study, Stanworth et al  
showed that the transfusion of platelet concentrates 
has a more controversial role in neonates, because the 
neonatal thrombocytopenia is one of the usual findings 
in premature neonates. 19 The chief causative factors 
include intrauterine growth retardation or maternal 
hypertension in which the infant presents with a low 
count in the immediate post-natal period, and extreme 
sepsis or necrotizing enterocolitis, which are the 
common illnesses associated with thrombocytopenia in 
neonates greater than 72 hours of age. 20   No evident 
relationship was found between platelet count and 
major hemorrhagic manifestation. Cardiorespiratory 
morbidity is considered to be the main contributing 
factor in occurrence of  periventricular and 
intraventricular hemorrhage in the neonatal age. 
Prophylactic platelet transfusions are given commonly 
in premature neonates having thrombocytopenia.21-23 
There is extensive difference in the pre-transfusion 
thresholds for platelet level and there has been a 
striking disparity in the practices of platelet 
transfusion between different hospitals in different 
countries. 
Von Lindern et al. piloted a data analysis research in 
the Netherlands, concluding that the neonatal 
intensive care units with a higher platelet transfusion 
rate did not have inferior chances of clinically relevant 
bleeding. 24  Two large observational studies have 
shown that most neonates with severe 
thrombocytopenia receive platelet transfusions 
according to previously recommended neonatal 
intensive care unit (NICU) thresholds (<50 x 109/L).  
Platelet transfusions can be a life-saving measure in 
patients with hemorrhagic symptoms  due to 
thrombocytopenia. Nevertheless, more than 95% of 
platelet transfusions in the NICU are used  
prophylactically , issued without any clinical signs of 
bleeding, the aim in mind being that the transfusion 
will avert hemorrhagic propensity. The benefits of 
these transfusions remain unverified. However, the 
risks of transfusion are well recognized in literature, 
and multiple use of platelet transfusions can enhance 
these possibilities.25  
 
Conclusion 
Frequency of thrombocytopenia in neonates at NICU 
is higher while the outcome of neonates receiving 
platelet transfusion is appreciable in our population.  
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